Genprex, Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Genprex, Inc. stock issued during period, value, conversion of units for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Genprex, Inc. stock issued during period, value, conversion of units for the quarter ending 2026-03-31 was $32.00, a 433.33% increase year-over-year.
- Genprex, Inc. stock issued during period, value, conversion of units for the quarter ending 2025-06-30 was $49.00.
- Genprex, Inc. stock issued during period, value, conversion of units for the quarter ending 2025-03-31 was $6.00.
- Genprex, Inc. stock issued during period, value, conversion of units for fiscal 2025 was $0.00.
- Genprex, Inc. stock issued during period, value, conversion of units for fiscal 2024 was -$1.00.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $32.00 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 | |
| 2025-06-30 | $49.00 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $6.00 10-Q · filed 2026-08-14 | |
| 2024-12-31 | -$1.00 10-K · filed 2026-03-30 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |